Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters











Publication year range
1.
Food Chem ; 138(2-3): 1172-82, 2013 Jun 01.
Article in English | MEDLINE | ID: mdl-23411228

ABSTRACT

The anticarcinogenic activity of hydroxytyrosyl ethyl ether (HTy-Et) compared to its precursor hydroxytyrosol (HTy) has been studied in human Caco-2 colon adenocarcinoma cells. 451 and 977 genes were differentially expressed in Caco-2 cells exposed to HTy or HTy-Et for 24h, respectively, compared with untreated cells (P<0.005; FDR=0), using Affymetrix microarrays. Results showed that both HTy and HTy-Et inhibited cell proliferation and arrested the cell cycle by up-regulating p21 and CCNG2 and down-regulating CCNB1 protein expression. HTy and HTy-Et also altered the transcription of specific genes involved in apoptosis, as suggested by the up-regulation of BNIP3, BNIP3L, PDCD4 and ATF3 and the activation of caspase-3. Moreover, these polyphenols up-regulated xenobiotic metabolizing enzymes UGT1A10 and CYP1A1, enhancing carcinogen detoxification. In conclusion, these results highlight that HTy and its derivative HTy-Et modulate molecular mechanisms involved in colon cancer, with HTy-Et being more effective than HTy.


Subject(s)
Anticarcinogenic Agents/pharmacology , Catechols/pharmacology , Colonic Neoplasms/genetics , Intestines/drug effects , Phenylethyl Alcohol/analogs & derivatives , Apoptosis/drug effects , Caco-2 Cells , Cell Cycle Checkpoints/drug effects , Colonic Neoplasms/drug therapy , Colonic Neoplasms/metabolism , Humans , Intestinal Mucosa/metabolism , Phenylethyl Alcohol/pharmacology , Transcriptome/drug effects
2.
J Food Prot ; 72(9): 1812-20, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19777880

ABSTRACT

Information implicating bacterial biofilms as contributory factors in the development of environmental bacterial resistance has been increasing. There is a lack of information regarding the role of biofilms within the microbial ecology of the gastrointestinal tract of food animals. This work used a continuous-flow chemostat model derived from the ceca of 7-day-old chicks to characterize these communities and their ability to neutralize invasion by Salmonella enterica serovar Typhimurium. We characterized and compared the biofilm and planktonic communities within these microcosms using automated ribotyping and the Analytical Profile Index biotyping system. Eleven species from eight different genera were identified from six culture systems. Klebsiella pneumoniae was isolated from all planktonic communities and four of the biofilm communities. Three of the communities resisted colonization by Salmonella enterica serovar Typhimurium, two communities suppressed growth, and one community succumbed to colonization. In cultures that resisted colonization, no Salmonella could be isolated from the biofilm; in cultures that succumbed to colonization, Salmonella was consistently found within the biofilms. This study was one of a series that provided a molecular-based characterization of both the biofilm and planktonic communities from continuous-flow culture systems derived from the cecal microflora of chicks, ranging in age from day-of-hatch to 14 days old. The one common factor relating to successful colonization of the culture was the presence of Salmonella within the biofilm. The capacity to sequester the introduced Salmonella into the biofilm appears to be a contributing factor to the inability of these cultures to withstand colonization by the Salmonella.


Subject(s)
Biofilms/growth & development , Cecum/microbiology , Consumer Product Safety , Food Contamination/prevention & control , Salmonella typhimurium/physiology , Animals , Animals, Newborn , Chickens , Colony Count, Microbial , Disease Susceptibility/veterinary , Humans , Poultry Diseases/prevention & control , Ribotyping , Salmonella Infections, Animal/prevention & control , Salmonella typhimurium/growth & development
3.
Proc Natl Acad Sci U S A ; 106(30): 12477-82, 2009 Jul 28.
Article in English | MEDLINE | ID: mdl-19597156

ABSTRACT

One of the largest contributions to biologically available nitrogen comes from the reduction of N(2) to ammonia by rhizobia in symbiosis with legumes. Plants supply dicarboxylic acids as a carbon source to bacteroids, and in return they receive ammonia. However, metabolic exchange must be more complex, because effective N(2) fixation by Rhizobium leguminosarum bv viciae bacteroids requires either one of two broad-specificity amino acid ABC transporters (Aap and Bra). It was proposed that amino acids cycle between plant and bacteroids, but the model was unconstrained because of the broad solute specificity of Aap and Bra. Here, we constrain the specificity of Bra and ectopically express heterologous transporters to demonstrate that branched-chain amino acid (LIV) transport is essential for effective N(2) fixation. This dependence of bacteroids on the plant for LIV is not due to their known down-regulation of glutamate synthesis, because ectopic expression of glutamate dehydrogenase did not rescue effective N(2) fixation. Instead, the effect is specific to LIV and is accompanied by a major reduction in transcription and activity of LIV biosynthetic enzymes. Bacteroids become symbiotic auxotrophs for LIV and depend on the plant for their supply. Bacteroids with aap bra null mutations are reduced in number, smaller, and have a lower DNA content than wild type. Plants control LIV supply to bacteroids, regulating their development and persistence. This makes it a critical control point for regulation of symbiosis.


Subject(s)
Amino Acids, Branched-Chain/metabolism , Pisum sativum/microbiology , Rhizobium leguminosarum/physiology , Symbiosis , ATP-Binding Cassette Transporters/genetics , ATP-Binding Cassette Transporters/metabolism , Amino Acids, Branched-Chain/biosynthesis , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Biological Transport , Biosynthetic Pathways , Host-Pathogen Interactions , Microscopy, Electron , Mutation , Nitrogen Fixation/physiology , Pisum sativum/genetics , Pisum sativum/metabolism , Rhizobium leguminosarum/genetics , Rhizobium leguminosarum/ultrastructure , Root Nodules, Plant/genetics , Root Nodules, Plant/metabolism , Root Nodules, Plant/microbiology
4.
Cell Microbiol ; 10(4): 958-84, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18031307

ABSTRACT

The biogenesis of the Salmonella-containing vacuole within mammalian cells has been intensively studied over recent years. However, the ability of Salmonella to sense and adapt to the intracellular environment of different types of host cells has received much less attention. To address this issue, we report the transcriptome of Salmonella enterica serovar Typhimurium SL1344 within epithelial cells and show comparisons with Salmonella gene expression inside macrophages. We report that S. Typhimurium expresses a characteristic intracellular transcriptomic signature in response to the environments it encounters within different cell types. The signature involves the upregulation of the mgtBC, pstACS and iro genes for magnesium, phosphate and iron uptake, and Salmonella pathogenicity island 2 (SPI2). Surprisingly, in addition to SPI2, the invasion-associated SPI1 pathogenicity island and the genes involved in flagellar biosynthesis were expressed inside epithelial cells at later stages of the infection, while they were constantly downregulated in macrophage-like cells. To our knowledge, this is the first report of the simultaneous transcription of all three Type Three Secretion Systems (T3SS) within an intracellular Salmonella population. We discovered that S. Typhimurium strain SL1344 was strongly cytotoxic to epithelial cells after 6 h of infection and hypothesize that the time-dependent changes in Salmonella gene expression within epithelial cells reflects the bacterial response to host cells that have been injured by the infection process.


Subject(s)
Epithelial Cells/microbiology , Salmonella typhimurium/growth & development , Salmonella typhimurium/genetics , Transcription, Genetic , Animals , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Caco-2 Cells , Cell Line , Epithelial Cells/cytology , Epithelial Cells/metabolism , Gene Expression Regulation, Bacterial , Genes, Bacterial/genetics , HeLa Cells , Humans , Immunohistochemistry , Macrophages/cytology , Macrophages/metabolism , Macrophages/microbiology , Microscopy, Electron, Transmission , Microscopy, Fluorescence , Oligonucleotide Array Sequence Analysis , Reverse Transcriptase Polymerase Chain Reaction , Salmonella typhimurium/ultrastructure
5.
J Microsc ; 218(Pt 1): 46-51, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15817062

ABSTRACT

IcsA is an autotransporter protein that plays a role in the virulence of Shigella bacteria. We have examined the cellular localization of a fusion of an IcsA fragment to the green fluorescent protein (GFP) expressed in Escherichia coli using a dual epifluorescence and scanning near-field optical microscope. By combining the data obtained from far-field with near-field microscopy of the same sample, discrimination between surface-bound fusion proteins and fusion proteins located in the cellular cytoplasm becomes possible. Furthermore, and for the first time, the inherent advantages in resolution of the near-field images provides highly specific details of the location of a GFP fusion protein on a bacterial cell surface.


Subject(s)
Bacterial Proteins/metabolism , DNA-Binding Proteins/metabolism , Microscopy, Fluorescence/methods , Microscopy, Scanning Probe/methods , Transcription Factors/metabolism , Bacterial Proteins/genetics , DNA-Binding Proteins/genetics , Escherichia coli/genetics , Escherichia coli/metabolism , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Microscopy, Atomic Force , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Shigella/genetics , Transcription Factors/genetics
6.
Methods ; 31(2): 113-9, 2003 Oct.
Article in English | MEDLINE | ID: mdl-12957568

ABSTRACT

Adoptive immunotherapy with donor T lymphocytes may be used as a treatment for relapsed leukemia after allogeneic hematopoietic stem cell transplantation (SCT). In vitro selected and expanded anti-leukemic T cells may be more effective in inducing a response in vivo. To identify the anti-leukemic reactivity of in vitro generated T cells, standard target cell read-out assays like the 51Cr-release assay are not always appropriate. We developed an assay in which the ability of T cells to antigen specifically inhibit the in vitro growth of leukemic progenitor cells in the presence of cytokines can be measured. This assay allows the evaluation of the cytolytic or suppressive potential of leukemia reactive T cells for prolonged periods of time. The assay is based on inhibition of [3H]thymidine incorporation by the leukemic progenitor cells induced by multiple hematopoietic growth factors. T cell clones with a known specificity were used to compare the analytic potential of the new assay with those of other cytotoxicity assays. Based on the results of the T cell clones, a modification of a limiting dilution assay was developed to identify anti-leukemic allogeneic T cells in HLA identical donor-recipient combinations selected on their ability to inhibit the in vitro growth of CML or AML progenitor cells, to be used for the generation of leukemia-reactive CTL lines for clinical use.


Subject(s)
Immunotherapy, Adoptive/methods , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/immunology , Leukemia, Myeloid/immunology , T-Lymphocytes, Cytotoxic/immunology , Acute Disease , Antigens, CD34/immunology , Cell Division/drug effects , Clone Cells , Colony-Forming Units Assay , Cytokines/immunology , Cytotoxicity, Immunologic , Dose-Response Relationship, Drug , Humans , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/pathology , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/therapy , Leukemia, Myeloid/pathology , Leukemia, Myeloid/therapy , Neoplastic Stem Cells/immunology , Neoplastic Stem Cells/pathology , Thymidine/metabolism , Tumor Cells, Cultured
7.
Infect Immun ; 68(12): 7141-3, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11083842

ABSTRACT

A putative pullulanase-encoding gene from Streptococcus pneumoniae was identified by screening a genomic expression library with human convalescent-phase serum. The 3,864-bp gene encoded a 143-kDa protein. Surface location and pullulanase activity of the protein, designated SpuA, was demonstrated. SpuA was present in all investigated pneumococcal isolates of different serotypes. The spuA 5' end was highly conserved among clinical isolates except for a 75-bp region. The properties of SpuA reported here indicate that this novel immunogenic surface protein might have potential as a vaccine target.


Subject(s)
Glycoside Hydrolases/immunology , Streptococcus pneumoniae/enzymology , Amino Acid Sequence , Base Sequence , Conserved Sequence , Glycoside Hydrolases/chemistry , Glycoside Hydrolases/genetics , Humans , Molecular Sequence Data , Streptococcus pneumoniae/immunology , Streptococcus pneumoniae/pathogenicity , Virulence
8.
Infect Immun ; 68(6): 3740-3, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10816539

ABSTRACT

A genomic expression library of Streptococcus pneumoniae was screened with a convalescent-phase serum for immunoreactive proteins. Six known and 17 unknown pneumococcal proteins were detected. Five of the known proteins were surface-located virulence factors, and eight of the unknown proteins were putative membrane proteins.


Subject(s)
Antibodies, Bacterial/blood , Antigens, Bacterial/isolation & purification , Bacterial Proteins/isolation & purification , Membrane Proteins/isolation & purification , Pneumococcal Infections/immunology , Bacterial Proteins/immunology , Convalescence , Membrane Proteins/immunology , Virulence
9.
Blood ; 94(4): 1201-8, 1999 Aug 15.
Article in English | MEDLINE | ID: mdl-10438707

ABSTRACT

Relapse of chronic myeloid leukemia (CML) in chronic phase after allogeneic stem cell transplantation (SCT) can be successfully treated by donor lymphocyte infusion (DLI). However, relapse of accelerated phase CML, blast crisis, or acute leukemia after allogeneic SCT are resistant to DLI in the majority of cases. In vitro-selected and expanded leukemia-reactive T-cell lines may be more effective in inducing an antileukemic response in vivo. To treat a patient with accelerated phase CML after allogeneic SCT, leukemia-reactive cytotoxic T-lymphocyte (CTL) lines were generated from her HLA-identical donor. Using a modification of a limiting dilution assay, T cells were isolated from the donor, selected based on their ability to inhibit the in vitro growth of CML progenitor cells, and subsequently expanded in vitro to generate CTL lines. Three CTL lines were generated that lysed the leukemic cells from the patient and inhibited the growth of leukemic progenitor cells. The CTL did not react with lymphocytes from donor or recipient and did not affect donor hematopoietic progenitor cells. The 3 leukemia-reactive CTL lines were infused at 5-week intervals at a cumulative dose of 3.2 x 10(9) CTL. Shortly after the third infusion, complete eradication of the leukemic cells was observed, as shown by cytogenetic analysis, fluorescence in situ hybridization, molecular analysis of BCR/ABL-mRNA, and chimerism studies. These results show that in vitro cultured leukemia-reactive CTL lines selected on their ability to inhibit the proliferation of leukemic progenitor cells in vitro can be successfully applied to treat accelerated phase CML after allogeneic SCT.


Subject(s)
Cytotoxicity, Immunologic , Immunotherapy, Adoptive , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/immunology , Leukemia, Myeloid, Accelerated Phase/immunology , Leukemia, Myeloid, Accelerated Phase/therapy , T-Lymphocytes, Cytotoxic/immunology , Adult , Female , HLA Antigens/immunology , Histocompatibility Testing , Humans , Leukemia, Myeloid, Accelerated Phase/physiopathology , Lymphocyte Activation , Remission Induction , T-Lymphocytes, Cytotoxic/transplantation , Transplantation, Homologous
10.
Leukemia ; 13(2): 241-9, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10025898

ABSTRACT

Despite the strong in vitro activity of some immunotoxins (ITs), clinical application did not result in complete cure. The outcome of therapy may be improved by combining ITs with IT-cytotoxicity enhancing agents. We studied the effect of various agents that influence the intracellular routing of ITs on the activity of the anti-B cell IT CD22-recombinant (rec) ricin A. In protein synthesis inhibition assays the carboxylic ionophores monensin and nigericin enhanced the activity of the IT 117- and 382-fold, respectively, against the cell line Daudi, and 81- and 318-fold, respectively, against the cell line Ramos. IT activity to Daudi and Ramos was enhanced to a lesser extent by the lysosomotropic amines chloroquine (14- and 11-fold, respectively) and NH4Cl (nine- and 10-fold, respectively). However, the combination of NH4Cl and chloroquine induced more than an additive effect (145- and 107-fold, respectively). Cytotoxicity was not influenced by brefeldin A, all-trans retinoic acid (ATRA), verapamil and perhexiline maleate. Bacitracin enhanced the IT cytotoxicity in contrast to the other protease inhibitors aprotinin, leupeptin and soybean trypsin inhibitor, albeit enhancement was weak (two-fold). The enhancers exerted only a negligible effect on bone marrow progenitor cells. We recently developed a flow cytometric cytotoxicity assay in which cell elimination can be assessed. In order to detect enhancement in this assay, we used 5 x 10(-11) M IT (approximately the 50% protein synthesis inhibiting dose (ID50)). This concentration killed 41% of the Daudi cells and 42% of the Ramos cells. In the presence of 10 nM monensin the IT killed 74% and 99% and in the presence of 10 nM nigericin 96% and 99% of the Daudi and Ramos cells, respectively. At 10(-8) M, CD22-rec ricin A eliminated malignant cells originating from three patients with B-CLL (0.42 log) and two with B-ALL (0.19 log) patients. Cytotoxicity to malignant cells was enhanced by NH4Cl, chloroquine, monensin and nigericin. The combination of NH4Cl and chloroquine enhanced the activity most effectively (up to 2.06 log). To determine the applicability of the IT in combination with enhancers in vivo we investigated the effect of human serum. Human serum inhibited IT activity which could not be restored by monensin and nigericin because of complete inhibition of these enhancers by serum. In contrast, chloroquine partially restored the activity of CD22-rec ricin A in the presence of human serum. We conclude that monensin, nigericin and the combination of NH4Cl and chloroquine can be used instead of NH4Cl to potentiate CD22-rec ricin A activity in purging autologous bone marrow transplants contaminated with malignant B cells. Chloroquine might be a promising enhancer of CD22-rec ricin A for treating patients in vivo.


Subject(s)
Antigens, CD/immunology , Antigens, Differentiation, B-Lymphocyte/immunology , Blood Physiological Phenomena , Burkitt Lymphoma/drug therapy , Cell Adhesion Molecules , Lectins , Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy , Protein Synthesis Inhibitors/toxicity , Ricin/toxicity , Bone Marrow Purging , Burkitt Lymphoma/pathology , Calcium Channel Blockers/pharmacology , Cell Line , Cell Survival/drug effects , Humans , Leukemia, Lymphocytic, Chronic, B-Cell/pathology , Lymphoproliferative Disorders/drug therapy , Lymphoproliferative Disorders/pathology , Recombinant Proteins/toxicity , Sialic Acid Binding Ig-like Lectin 2 , Tumor Cells, Cultured
11.
Plant Cell Rep ; 16(1-2): 54-7, 1996 Nov.
Article in English | MEDLINE | ID: mdl-24178654

ABSTRACT

The gene coding for isochorismate synthase (EC 5.4.99.6) was amplified by the polymerase chain reaction fromEscherichia coli, cloned into a binary vector. and mobilised intoAgrobacterium rhizogenes LBA9402 which was used to transformRubia peregrina. Transgenic roots containing bacterial isochorismate synthase cDNA expressed twice as much isochorismate synthase activity (4.88 pkat/mg protein) as the control roots (2.45 pkat/mg protein) after 10 days in culture, and accumulatedca. 20% higher levels of total anthraquinones after 30 days in culture. Whilst the amount of total alizarin (free and bound) in the transgenic roots was 30% higher than in control roots, the level of free alizarin wasca. 85% higher.

12.
Eur J Biochem ; 212(2): 431-40, 1993 Mar 01.
Article in English | MEDLINE | ID: mdl-8444181

ABSTRACT

Anthranilate synthase (EC 4.1.3.27) has been purified from cell cultures of Catharanthus roseus by poly(ethylene glycol) precipitation/fractionation and subsequent separation by anion exchange on Q-Sepharose, Orange A dye chromatography, Mono Q anion-exchange chromatography and Superose 6 gel filtration. By analogy to anthranilate synthases from other sources it does look like the enzyme is a tetramer composed of two large and two small subunits, with molecular mass 67 and 25.5 +/- 0.5 kDa, respectively. The molecular mass determined by gel filtration was 143 +/- 5 kDa. The enzyme had a pI of 5.1 determined by chromatofocusing. The pH optimum was between pH 7.5 and pH 8.3, but the type of buffer used affected the results. The enzyme could utilize NH4+ as ammonium donor instead of glutamine. The enzyme showed normal Michaelis-Menten kinetics with respect to the substrates L-glutamine and chorismate, and the cofactor Mg2+, Km values for L-glutamine was determined to be 0.37 +/- 0.05 mM, for chorismate 67 +/- 3 microM, and for MgCl2 0.26 +/- 0.03 mM respectively. Anthranilate synthase was inhibited by L-tryptophan, tryptamine and D-tryptophan (with L-tryptophan being the best inhibitor). The enzyme was allosterically regulated showing positive cooperatively of chorismate binding at higher concentrations of tryptophan. For a tryptophan concentration of 20 microM the Hill coefficient was determined to be 2. The tryptophan binding sites showed positive cooperatively for higher concentrations of chorismate. The purified enzyme did not contain anthranilate-5-phosphoribosylpyrophosphate phosphoribosyltransferase activity and is thus not of the same type as the well characterized Salmonella typhimurium anthranilate synthase/phosphoribosyl pyrophosphate transferase bifunctional type.


Subject(s)
Anthranilate Synthase/isolation & purification , Plants/enzymology , Anthranilate Synthase/analysis , Anthranilate Synthase/chemistry , Bacteria/enzymology , Cells, Cultured , Enzyme Stability , Feedback , Hydrogen-Ion Concentration , Isoelectric Point , Isoenzymes/analysis , Kinetics , Molecular Weight , Substrate Specificity , Tryptophan/pharmacology
13.
Eur J Biochem ; 200(3): 783-7, 1991 Sep 15.
Article in English | MEDLINE | ID: mdl-1915350

ABSTRACT

Methanoculleus thermophilicum was shown to contain two pterin derivatives. The structures of these pterin derivatives were established from amino acid analysis, 1H-NMR and fast-atom bombardment mass spectrometry data. One of the pterins was identified as tatiopterin-O, an aspartyl derivative of methanopterin with a proton at position 7 of the pterin moiety. The other pterin, which we named thermopterin, differed in the structure of the aniline group, containing two additional hydroxyl residues. The IUPAC name of thermopterin is N-[-1'-(2"-amino-4"-hydroxy-6"-pteridinyl)ethyl]-4- [2',3',4',5'-tetrahydroxypent-1'-yl(5'----1") O-alpha-ribofuranosyl-5"-phosphoric acid]-2,5-dihydroxyaniline, in which the phosphate group is esterified with alpha-hydroxyglutarylaspartic acid.


Subject(s)
Euryarchaeota/chemistry , Pterins/isolation & purification , Amino Acids/analysis , Magnetic Resonance Spectroscopy , Molecular Structure , Pterins/chemistry , Spectrophotometry
SELECTION OF CITATIONS
SEARCH DETAIL